Skip to main content

Table 4 Reduced work ability before and after DAA therapy (n = 115)

From: Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents

RWA as %

After DAA therapy

Overall

Before DAA therapy

 

0

20

30–40

50–60

70–80

90–100

n

%

0

6

0

0

0

0

0

6

5.2

20

38

7

1

0

0

0

46

40

30–40

15

4

7

1

0

0

27

23.5

50–60

2

2

10

6

0

0

20

17.4

70–80

1

0

1

0

4

3

9

7.8

90–100

0

0

0

0

4

3

7

6.1

Overall

n

62

13

19

7

8

6

115

 

%

53.9

11.3

16.5

6.1

7

5.2

100

100

  1. RWA reduced work ability, DAA direct-acting antiviral agents